臺北榮民總醫院蘇澳分院
*:::
*網站地圖*回首頁*English*常見問答*意見信箱*RSS*雙語詞彙*分類檢索*網路郵局*住院費用繳納回報  

最新動態

認識本院

就醫資訊

醫療團隊

科別介紹

醫學園地

便民服務

連結:網路掛號(另開新視窗) 連結:門診時刻表 連結:看診進度查詢(另開新視窗)
*
  :::醫療團隊
  *

內科部

*
  *

一般內科

*
  *

肝膽腸胃科

*
  *

心臟內科

*
  *

腎臟內科

*
  *

神經內科

*
  *

胸腔內科

*
  *

免疫風濕科

*
  *

感染科

*
  *

新陳代謝科

*
  *

外科部

*
  *

一般外科

*
  *

大腸直腸外科

*
  *

消化外科

*
  *

心臟外科

*
  *

泌尿外科

*
  *

骨科

*
  *

整形外科

*
  *

麻醉科

*
  *

神經外科

*
  *

各大科部

*
  *

家庭醫學科

*
  *

婦產科

*
  *

精神科

*
  *

復健科

*
  *

眼科

*
  *

耳鼻喉科

*
  *

牙科

*
  *

小兒科

*
  *

放射科

*
  *

職業醫學科

*
  *

急診醫學科

*
  *

皮膚科

*
  *

傳統醫學科

*
  *

醫學美容

*


*:::
*

* 目前位置:首頁 > 醫師團隊 > 外科部-泌尿外科 * 回上一頁
*
泌尿外科
*
更新日期: 2021-11-03
*

*
*

蔣智宏

黃子豪

*


*

醫師介紹

*
*

蔣智宏 主任


外科部-泌尿外科 蔣智宏 主任
學歷 國防醫學院醫學系 (1991/7-1998/7)
陽明大學醫學院藥理學博士 (2010/8-2015/7)
臺大醫學院泌尿科兼任助理教授 (2016/8-迄今)
教育部部定副教授 (2020/1-迄今)
*
經歷 北榮員山暨蘇澳分院泌尿外科主任(2011/1-迄今)
北榮員山分院教學研究中心主任(2016/6-迄今)
臺北榮民總醫院泌尿部特約醫師(2011/1-迄今)
臺大醫院泌尿部兼任主治醫師(2014/1-迄今)
第3屆臺灣楓城泌尿學會理事 (2020/1/12-迄今)
臺灣泌尿科醫學會第21屆 專科醫師甄審委員會委員(2018/8/20-迄今)
陽明大學藥理學科暨研究所第2屆所友會理事 (2017/5-迄今)
*
專長 達文西機器人手術(臺大醫院)、泌尿腫瘤[攝護腺癌(宜蘭累積超過500例經驗)、膀胱癌、輸尿管癌、腎臟癌]、攝護腺肥大、180瓦綠光雷射手術(宜蘭累積超過230例經驗)、腎結石與輸尿管結石治療(宜蘭累積超過500例經驗)、尿路感染、膀胱功能障礙、包皮發炎與尿道下裂、性功能障礙、男性不孕症、女性尿失禁、精索靜脈曲張等。
*
著作 蔣智宏的學術文章(~至2021/11):
  1. Chiu ST, Cheng YT, Pu YS, Lu YC, Hong JH, Chiang CH(蔣智宏) (通訊作者)* and Hung CY*. Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection. Accepted by Front Oncol. 2021 Oct 29. (2020 IF:6.2、Ranking 62/242 = 25.6%)
  2. Hong JH, Lee PAH, Lu YC, Huang CY, Chen CH, Chiang CH(蔣智宏), Chow PM, Jaw FS, Wang CC, Huang CY, Wang TW, Liu JH, Wang HT. Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease. Urol Oncol. 2020;38(5):465-475. (2020 IF:3.5、Ranking 32/89 = 36.0%)
  3. Cheng YT, Huang CY, Chen CH, Chiu ST, Hong JH, Pu YS, Liu SP, Lu YC, Chang YK, Chang HC, Huang KH, Lee YJ, Chow PM, Chiang IN, Hung SH, Chiang CH(蔣智宏) (通訊作者)*. Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy. Sci Rep. 2020;10(1):776 (2020 IF:4.4、Ranking 17/72 = 23.6%)
  4. Liu YC, Lin KH, Hsieh JH, Chung JG, Tan ZL, Hsu FT, Chiang CH(蔣智宏) (通訊作者)*. Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer. In Vivo. 2019;33(6):1865-1877. (2020 IF:2.2、113/140 = 80.7%)
  5. Chiang CH(蔣智宏), Yeh CY, Chung JG, Chiang IT, Hsu FT. Amentoflavone induces apoptosis and reduces expression of anti-apoptotic and metastasis-associated proteins in bladder cancer. Anticancer Res. 2019;39(7):3641-3649. (2020 IF:2.5、Ranking 210/242 = 86.8%)
  6. Chiang CH(蔣智宏), Chung JG, Hsu FT*. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF κB-modulated tumor progression in bladder cancer in vitro and in vivo. Environ Toxicol. 2019;34(6):679-688. (2020 IF:4.1、Ranking 31/93 = 33.3%)
  7. Chiu PK, Ng CF, Semjonow A, Zhu Y, Vincendeau S, Houlgatte A, Lazzeri M, Guazzoni G, Stephan C, Haese A, Bruijne I, Teoh JY, Leung CH, Casale P, Chiang CH(蔣智宏), Tan LG, Chiong E, Huang CY, Wu HC, Nieboer D, Ye DW, Bangma CH, Roobol MJ. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol. 2019;75(4):558-561. (2020 IF:20.1、2/89 = 2.2%)
  8. Cheng YT, Chiang CH(蔣智宏), Pu YS, Liu SP, Lu YC, Chang YK, Chang HC, Huang KH, Lee YJ, Chow PM, Hung SC, Huang CY. The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center. J Formos Med Assoc. 2019;118(1 Pt 2):260-267. (2020 IF:3.3、Ranking 53/167 = 31.7%)
  9. Hsu FT, Sun CC, Wu CH, Lee YJ, Chiang CH(蔣智宏) (通訊作者)*, Wang WS*. Regorafenib Induces Apoptosis and Inhibits Metastatic Potential of Human Bladder Carcinoma Cells. Anticancer Res. 2017;37(9):4919-26. (2020 IF:2.5、Ranking 210/242 = 86.8%)
  10. Chiang CH(蔣智宏), Wu WW, Li HY, Chien Y, Sun CC, Peng CH, Lin AT, Huang CS, Lai YH, Chiou SH, Hung SI, Chang YL, Lan YT, Liu DM, Chien CS, Huo TI, Lee SD, Wang CY. Enhanced Antioxidant Capacity of Dental Pulp-Derived iPSC-Differentiated Hepatocytes and Liver Regeneration by Injectable HGF-Releasing Hydrogel in Fulminant Hepatic Failure. Cell Transplant. 2015;24(3):541-59. (2020 IF:4.1、Ranking 8/25 = 32.0%)
  11. Chiang CH(蔣智宏), Huo TI, Sun CC, Hsieh JH, Chien Y, Lu KH, Lee SD. Induced pluripotent stem cells and hepatic differentiation. J Chin Med Assoc. 2013;76:599-605. (2020 IF:2.7、Ranking 62/167 = 37.1%)
  12. Chang HM, Liao YW, Chiang CH(蔣智宏), Chen YJ, Lai YH, Chang YL, Chen HL, Jeng SY, Hsieh JH, Peng CH, Li HY, Chien Y, Chen SY, Chen LK, Huo TI. Improvement of Carbon Tetrachloride-Induced Acute Hepatic Failure by Transplantation of Induced Pluripotent Stem Cells without Reprogramming Factor c-Myc. Int J Mol Sci. 2012;13(3):3598-617 (2020 IF:5.9、Ranking 67/295 = 22.7%)
  13. Chiang CH(蔣智宏), Chang CH, Huang HC, Chen YJ, Tsai PH, Jeng SY, Hung SI, Hsieh JH, Huang HS, Chiou SH*, Lee FY, Lee SD. Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury. J Biomed Biotechnol. 2011;2011:219060 (2020 IF:3.4、Ranking 70/159 = 44.0%)
  14. Li HY, Chien Y, Chen YJ, Chen SF, Chang YL, Chiang CH(蔣智宏), Jeng SY, Chang CM, Wang ML, Chen LK, Hung SI, Huo TI, Lee SD, Chiou SH*. Reprogramming Induced Pluripotent Stem Cells in the Absence of c-Myc for Differentiation into Hepatocyte-like Cells. Biomaterials. 2011;32:5994-6005 (2020 IF:12.5、Ranking 3/89 = 3.4%)
  15. Chiang CH(蔣智宏), Hong CJ, Chang YH, Chang LS, and Chen KK*. Human Kallikrein-2 Gene Polymorphism is Associated with the Occurrence of Prostate Cancer. J Urol. 2005;173:429-32 (2020 IF:7.5、Ranking 10/89 = 11.2%)
  16. Chiang CH(蔣智宏), Chen KK, Chang LS, and Hong CJ*. The Impact of Polymorphism on Prostate Specific Antigen Gene on the Risk, Tumor Volume and Pathological Stage of Prostate Cancer. J Urol. 2004;171:1529-32 (2020 IF:7.5、Ranking 10/89 = 11.2%)
  17. Chiang CH(蔣智宏), Chang LS, and Chen KK*. The Role of Hematuria in Predicting the Outcome of Severe Acute Respiratory Syndrome. J Taiwan Urol Assoc. 2004;15:59-64
*
*






 
**
*

到最上面

*